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M etabolic syndrome increases riskfor cardiovascular disease (1,2).The diagnosis of metabolic syn-
drome in patients might hold promise for
enhanced prevention of cardiovascular
disease. Currently, there is no consensus
on the diagnosis of metabolic syndrome
in children and adolescents, with variable
prevalence of metabolic syndrome from
4.2 to 32% in several populations (3–5).
The highest rates of metabolic syndrome
were found in adolescents with Latino or
African backgrounds (3,6). However, this
racial/ethnic predisposition to metabolic
syndrome is not well defined. The Brazil-
ian population has a high degree of mis-
cegenation that includes a mix of indige-
nous people, Afro- and Euro-Brazilians,
and a widespread Latin ancestry. We do
not know if this genetic and environmen-
tal diversity can modify the prevalence of
metabolic syndrome or its relationship to
obesity. In this study, we determine the
prevalence of metabolic syndrome in a
group of Brazilian adolescents with a fam-
ily history of type 2 diabetes.
RESEARCH DESIGN AND
METHODS— Inclusion criteria were
age between 10 and 19 years, good health,
and family history of type 2 diabetes. The
Sa˜o Paulo Federal University Ethics Com-
mittee reviewed and approved the study.
Informed consent and assent were ob-
tained from all participants or relatives.
BMI cut points for overweight and obesity
by sex and age in children were defined as
25 and 30 kg/m2, respectively, at age 18
years. These criteria were chosen because
of the inclusion of Brazilian children and
adolescents in the original study (7). The
adolescents were stratified into three
groups: G0 (normal), G1 (overweight),
and G2 (obese) according to the above cri-
teria. Blood pressure was measured on the
right arm using a mercury-gravity ma-
nometer with proper cuff size. Children
whose systolic blood pressure (SBP) or di-
astolic blood pressure exceeded the 95th
percentile for age and sex (8) were con-
sidered to have hypertension (high blood
pressure). After a 12-h overnight fast,
baseline samples were obtained for mea-
surements of plasma glucose, lipids (total,
HDL, and LDL cholesterol and triglycer-
ides), and serum insulin. Thereafter, an
oral glucose load (1.75 g/kg body wt [up
to a maximum of 75 g]) was given, and
after 2 h, plasma glucose and serum insu-
lin were measured. Glucose tolerance was
classified according to American Diabetes
Association criteria (9). Metabolic syn-
drome was devised as a child-specific def-
inition, by the presence of at least three of
the following factors: BMI 97th percentile
for age/sex, high blood pressure and hy-
pertriglyceridemia (130 mg/dl) (10),
low HDL cholesterol (35 mg/dl) (10),
insulin resistance (defined as homeostasis
model assessment [HOMA] of insulin re-
sistance [HOMA-IR] 2.5), impaired
glucose tolerance, impaired fasting glu-
cose, or type 2 diabetes (4). Our study
was based on a child-specific definition,
although we used the cutoff for obesity as
the equivalent to a BMI of 30 kg/m2 at age
18 years (7). HOMA, -cell function, and
insulin sensitivity were calculated by the
HOMA Model Program (University of
Oxford, Oxford, U.K.). HOMA-IR was
calculated as (fasting serum insulin [U/
ml])  (fasting plasma glucose [mmol 
l1  dl1])/22.5 (11). Values are ex-
pressed as means  SD, and when not
normally distributed, they were ln trans-
formed for analysis (version 1.0, Sigma-
Stat; Systat Software). P values 0.05
were considered statistically significant.
RESULTS— Characteristics of adoles-
cents are presented in Table 1. There was
no significant difference in birth weight,
age, sex, height, Tanner stage, and phys-
ical activity among the three groups.
HOMA-IR, in the whole group (n  99),
was found to be correlated with BMI (r
0.46, P  0.001), visceral obesity (waist)
(r 0.52, P 0.001), SBP (r 0.29, P
0.005), triglycerides (r  0.35, P 
0.005), 2-h plasma glucose (r 0.28, P
0.05), and 2-h serum insulin (r  0.47,
P  0.001) on an oral glucose tolerance
test. The 2-h plasma glucose, also in the
whole group, was correlated with total
cholesterol (r  0.25, P  0.05), LDL
cholesterol (r 0.25, P 0.05), and 2-h
serum insulin (r 0.41, P 0.005). For-
ward stepwise regression analysis was
conducted to examine the effect of the fol-
lowing variables on HOMA-IR in the
whole group: BMI, waist, triglycerides,
SBP, 2-h plasma glucose, and 2-h serum
insulin. The variables that remained sig-
nificant were waist (R2  0.275, P 
0.005) and 2-h serum insulin (R2 
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0.365, P  0.005). The same was con-
ducted to 2-h plasma glucose (variables:
total cholesterol, LDL cholesterol, and
2-h serum insulin). Variables selected in
the mode were LDL cholesterol (R2 
0.172, P  0.05) and 2-h serum insulin
(R2  0.212, P  0.005).
The overall prevalence of metabolic
syndrome was 6% (95% CI 5.9–6.1). In
G0 and G1, none of the subjects had met-
abolic syndrome, while in G2 the preva-
lence was 26.1% (8.2–45.6). In the whole
group, the characteristics of metabolic
syndrome included obesity (23.4%),
HOMA-IR 2.5 (22.2%), high blood
pressure (18.2%), hypertriglyceridemia
(8.1%), and low HDL cholesterol (8.1%).
In G0, the highest prevalence was high
blood pressure (13%), followed by insu-
lin resistance (10.9%), high triglycerides
(6.5%), and low HDL cholesterol (4.3%).
In G1, the more prevalent characteristic
was insulin resistance (23%), followed by
high blood pressure (10%), high triglyc-
erides (6.7%) and low HDL cholesterol
(6.7%). In G2, where all of the individuals
were obese, the prevalence was insulin re-
sistance (43.5%), high blood pressure
(39.1%), low HDL cholesterol (17.4%),
and high triglycerides (13%).
CONCLUSIONS— We present data
on metabolic syndrome in the adolescent
population not well described previously,
with most of the present literature focus-
ing on the U.S. or Europe. The prevalence
of metabolic syndrome was 6% in the
whole group, and 24.2% of these adoles-
cents had at least one feature of metabolic
syndrome. In the obese adolescents (G2),
the prevalence of metabolic syndrome
was 26.1%. Similar metabolic syndrome
prevalence has been shown in diverse
populations (3–5,12), despite limitations
of comparison. Insulin resistance and
obesity have been identified as main fea-
tures of metabolic syndrome in our nor-
mal glucose tolerant adolescents. The
regression analysis has shown that vis-
ceral obesity (waist) and 2-h serum insu-
lin were the main factors for HOMA-IR
and LDL cholesterol and 2-h serum insu-
lin for 2-h plasma glucose. HOMA-IR was
also correlated with triglycerides, similar
to what was found in the Bogalusa Heart
Study from a biracial community (13).
This last study showed that blood pres-
sure has a positive correlation with fasting
insulin (even after adjustment for BMI) at
as early as 5 years of age (14). The preva-
lence of high blood pressure in our ado-
lescents was higher compared with other
studies (15).
In summary, we show that the preva-
lence of metabolic syndrome in a group of
normal glucose tolerant Brazilian adoles-
cents with family history of type 2 diabe-
tes is similar to several studies conducted
in the U.S. and Europe, although there are
differences in the metabolic syndrome
characteristics among all groups.
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Table 1—Characteristics of normal BMI (G0), overweight (G1), and obese (G2) groups
G0 G1 G2
n 46 30 23
Age (years) 14.4  2.7 15.7  2.6 14.3  2.7
Sex (% male) 52.0 46.7 43.5
Race (% white) 63.0 63.0 56.5
Weight (kg)* 50.2  12.3 66.5  10.0 81.6  14.4
Height (cm) 158.3  11.4 160.4  10.5 159.3  9.6
BMI (kg/m2)* 19.7  2.7 25.6  1.7 32.0  4.3
Tanner (median) 5.0 5.0 5.0
SBP (mmHg)† 113.8  11.5 117.5  13.2 130.6  15.3
DBP (mmHg) 74.3  12.5 77.2  9.0 82.8  11.9
Acanthosis nigricans (%)¶ 8.7 16.7 65.2
Waist (cm)* 72.7  9.3 88.8  8.9 106.2  8.6
Birth weight (g) 3,121.5  651.3 3,450.0  737.7 3,633.4  992.7
Total cholesterol (mg/dl) 147.1  30.2 157.2  29.6 160.6  35.1
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LDL cholesterol (mg/dl) 88.0  25.8 98.6  24.4 99.2  31.2
Triglycerides (mg/dl)† 76.5  34.0 75.9  26.8 100.0  39.1
Uric acid (mg/dl)‡ 4.2  1.0 4.9  1.3 5.4  1.6
Fasting glucose (mg/dl) 79.7  9.7 81.3  9.8 81.1  11.7
2-h blood glucose (mg/dl) 84.6  19.2 91.5  16.8 88.7  15.5
Fasting serum insulin (U/ml)‡ 7.3  3.6 10.0  4.6 13.9  6.7
2-h serum insulin (U/ml)‡ 33.7  26.6 50.1  41.6 70.1  41.1
-Cell function (%)§ 104.2  36.7 158.1  168.0 173.5  89.2
Insulin sensitivity (%)‡ 161.2  103.2 101.8  44.8 90.4  77.0
HOMA-IR‡ 1.5  0.8 2.0  1.0 2.8  1.5
Data are means  SD unless otherwise indicated. *P  0.05 for G0 vs. G1, G0 vs. G2, and G1 vs. G2; †P 
0.05 for G2 vs. G0 and G2 vs. G1; ‡P 0.05 for G0 vs. G2 and G0 vs. G1; §P 0.05 for G2 vs. G0. DBP, diastolic
blood pressure.
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